Loading…
Sectoral / Thematic · quant Mutual Fund · AMFI code 151853quant Healthcare Fund
Disclosed for 38 months, Aug 2023 to Sep 2026.
Portfolio value
₹396 Cr
up ₹26.1 Cr vs Mar 2025
- Stocks held
- 14
- down 1 vs Mar 2025
- Top 10 weight
- 71.5%
- of the portfolio in its ten largest
- Cash & debt
- 0.9%
- cash, money market and debt
quant Healthcare Fund is an active equity fund in the Sectoral / Thematic category from quant Mutual Fund. In April 2025 it disclosed 14 stocks worth ₹396 Cr, up ₹26.1 Cr from Mar 2025. Its largest positions were Divi's Laboratories Limited (9.6%), Aster DM Healthcare Limited (9.0%), RPG Life Sciences Limited (7.9%); the ten largest together made up 71.5% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 66.0% of its equity. Cash and debt stood at 0.9%. Compared with Mar 2025 the fund entered 1 new stock and exited 2.
Against 229 other Sectoral / Thematic funds
Concentration
94%
Top-10 weight is higher than 94% of peers
Breadth
2%
Holds more stocks than 2% of peers
Cash
11%
Holds more cash than 11% of peers
What these mean: concentration · cash
Holdings in April 2025
Download CSVEvery line the fund disclosed, with the change against Mar 2025. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Divi's Laboratories Limited | 9.59% | up 0.02 pts | ₹38 Cr | up ₹2.6 Cr | Added |
| Aster DM Healthcare Limited | 8.99% | down 0.22 pts | ₹35.6 Cr | up ₹1.5 Cr | Added |
| RPG Life Sciences Limited | 7.95% | down 1.33 pts | ₹31.5 Cr | down ₹2.9 Cr | Trimmed |
| Torrent Pharmaceuticals Limited | 7.03% | down 0.28 pts | ₹27.8 Cr | up ₹79 L | Added |
| Reliance Industries Limited | 6.89% | up 0.20 pts | ₹27.3 Cr | up ₹2.5 Cr | Added |
| Glenmark Life Sciences Limited | 6.87% | down 0.33 pts | ₹27.2 Cr | up ₹56 L | Added |
| Aurobindo Pharma Limited | 6.74% | down 0.07 pts | ₹26.7 Cr | up ₹1.5 Cr | Added |
| Lupin Limited 29/05/2025 Derivative | 6.46% | up 6.46 pts | ₹25.6 Cr | up ₹25.6 Cr | New |
| Zydus Wellness Limited | 5.72% | down 0.11 pts | ₹22.7 Cr | up ₹1.1 Cr | Added |
| Pfizer Limited | 5.23% | up 0.01 pts | ₹20.7 Cr | up ₹1.4 Cr | Added |
| SMS Pharmaceuticals Limited | 4.96% | up 1.15 pts | ₹19.6 Cr | up ₹5.6 Cr | Added |
| Sequent Scientific Limited | 4.90% | up 0.14 pts | ₹19.4 Cr | up ₹1.8 Cr | Added |
| HFCL Limited | 4.79% | down 0.32 pts | ₹19 Cr | up ₹7 L | Held |
| Dr. Reddy's Laboratories Limited 29/05/2025 Derivative | 4.45% | up 4.45 pts | ₹17.6 Cr | up ₹17.6 Cr | New |
| Lupin Limited | 3.02% | up 3.02 pts | ₹11.9 Cr | up ₹11.9 Cr | New |
| Aurobindo Pharma Limited 29/05/2025 Derivative | 2.91% | up 2.91 pts | ₹11.5 Cr | up ₹11.5 Cr | New |
| Suraksha Diagnostic Limited | 2.57% | up 0.19 pts | ₹10.2 Cr | up ₹1.4 Cr | Added |
| 91 Days Treasury Bill 17-Jul-2025 Debt | 1.25% | up 1.25 pts | ₹4.9 Cr | up ₹4.9 Cr | New |
| Cash, TREPS & receivables | −0.31% | up 1.78 pts | −₹1.2 Cr | up ₹6.5 Cr | Added |
What changed, Mar 2025 to Apr 2025
New New positions (1)
- Lupin Limited3.0% · ₹11.9 Cr
Exited Exited (2)
- IPCA Laboratories Limitedwas 7.4% · ₹27.5 Cr
- Zydus Lifesciences Limitedwas 7.0% · ₹26 Cr
Added Biggest additions
- SMS Pharmaceuticals Limitedup ₹5.6 Cr (+1.15% pts)
- Divi's Laboratories Limitedup ₹2.6 Cr (+0.02% pts)
- Reliance Industries Limited ₹2.5 Cr (+0.20% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Mar 2025, the weight rose most in Healthcare Services (+1.7 pts) and Petroleum Products (+1.2 pts), and fell most in Pharmaceuticals & Biotechnology (−4.0 pts).
- Healthcare Services11.9% → 13.6%+1.7 pts
- Petroleum Products6.9% → 8.1%+1.2 pts
- Food Products6.0% → 6.7%+0.7 pts
- Telecom - Services5.2% → 5.6%+0.4 pts
- Pharmaceuticals & Biotechnology70.1% → 66.0%−4.0 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Apr 2024 | Oct 2024 | Jan 2025 | Mar 2025 | Apr 2025 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 47.8% | 68.9% | 69.3% | 70.1% | 66.0% |
| Healthcare Services | 16.1% | 10.9% | 11.6% | 11.9% | 13.6% |
| Petroleum Products | 9.7% | 7.3% | 7.1% | 6.9% | 8.1% |
| Food Products | — | 6.0% | 6.0% | 6.0% | 6.7% |
| Telecom - Services | — | 6.9% | 6.0% | 5.2% | 5.6% |
Allocation in Apr 2025change vs Mar 2025
- Pharmaceuticals & Biotechnology (9)66.0%▼ 4.0 pts
- Healthcare Services (2)13.6%▲ 1.7 pts
- Petroleum Products (1)8.1%▲ 1.2 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Apr 2025
0.9%
▲ 0.3 pts vs Mar 2025
- Cash alone
- −0.3%
- cash and net receivables
- A year earlier
- 1.1%
- Apr 2024 · now ▼ 0.2 pts
- Last 12 months
- 0.4% – 7.0%
- lowest to highest · record 7.5% in Feb 2024
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.